118 related articles for article (PubMed ID: 17254945)
1. Translational dysregulation by Pateamine A.
Korneeva NL
Chem Biol; 2007 Jan; 14(1):5-7. PubMed ID: 17254945
[TBL] [Abstract][Full Text] [Related]
2. RNA-mediated sequestration of the RNA helicase eIF4A by Pateamine A inhibits translation initiation.
Bordeleau ME; Cencic R; Lindqvist L; Oberer M; Northcote P; Wagner G; Pelletier J
Chem Biol; 2006 Dec; 13(12):1287-95. PubMed ID: 17185224
[TBL] [Abstract][Full Text] [Related]
3. Substrate-dependent targeting of eukaryotic translation initiation factor 4A by pateamine A: negation of domain-linker regulation of activity.
Low WK; Dang Y; Bhat S; Romo D; Liu JO
Chem Biol; 2007 Jun; 14(6):715-27. PubMed ID: 17584618
[TBL] [Abstract][Full Text] [Related]
4. Stopping trouble before it starts.
Clardy J
ACS Chem Biol; 2006 Feb; 1(1):17-9. PubMed ID: 17163634
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of eukaryotic translation initiation by the marine natural product pateamine A.
Low WK; Dang Y; Schneider-Poetsch T; Shi Z; Choi NS; Merrick WC; Romo D; Liu JO
Mol Cell; 2005 Dec; 20(5):709-22. PubMed ID: 16337595
[TBL] [Abstract][Full Text] [Related]
6. Selective targeting of the DEAD-box RNA helicase eukaryotic initiation factor (eIF) 4A by natural products.
Shen L; Pelletier J
Nat Prod Rep; 2020 May; 37(5):609-616. PubMed ID: 31782447
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the mechanism of action of a potent pateamine A analog, des-methyl, des-amino pateamine A (DMDAPatA).
Kommaraju SS; Aulicino J; Gobbooru S; Li J; Zhu M; Romo D; Low WK
Biochem Cell Biol; 2020 Aug; 98(4):502-510. PubMed ID: 32008367
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation.
Bordeleau ME; Matthews J; Wojnar JM; Lindqvist L; Novac O; Jankowsky E; Sonenberg N; Northcote P; Teesdale-Spittle P; Pelletier J
Proc Natl Acad Sci U S A; 2005 Jul; 102(30):10460-5. PubMed ID: 16030146
[TBL] [Abstract][Full Text] [Related]
9. Isolation and identification of eukaryotic initiation factor 4A as a molecular target for the marine natural product Pateamine A.
Low WK; Dang Y; Schneider-Poetsch T; Shi Z; Choi NS; Rzasa RM; Shea HA; Li S; Park K; Ma G; Romo D; Liu JO
Methods Enzymol; 2007; 431():303-24. PubMed ID: 17923240
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of translation targeting eukaryotic translation initiation factor 4A.
Cencic R; Galicia-Vázquez G; Pelletier J
Methods Enzymol; 2012; 511():437-61. PubMed ID: 22713332
[TBL] [Abstract][Full Text] [Related]
11. Stress Granule-Inducing Eukaryotic Translation Initiation Factor 4A Inhibitors Block Influenza A Virus Replication.
Slaine PD; Kleer M; Smith NK; Khaperskyy DA; McCormick C
Viruses; 2017 Dec; 9(12):. PubMed ID: 29258238
[TBL] [Abstract][Full Text] [Related]
12. Differential action of pateamine A on translation of genomic and subgenomic mRNAs from Sindbis virus.
González-Almela E; Sanz MA; García-Moreno M; Northcote P; Pelletier J; Carrasco L
Virology; 2015 Oct; 484():41-50. PubMed ID: 26057151
[TBL] [Abstract][Full Text] [Related]
13. Creating novel translation inhibitors to target pro-survival proteins in chronic lymphocytic leukemia.
Chen R; Zhu M; Chaudhari RR; Robles O; Chen Y; Skillern W; Qin Q; Wierda WG; Zhang S; Hull KG; Romo D; Plunkett W
Leukemia; 2019 Jul; 33(7):1663-1674. PubMed ID: 30700841
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of nonsense-mediated mRNA decay by the natural product pateamine A through eukaryotic initiation factor 4AIII.
Dang Y; Low WK; Xu J; Gehring NH; Dietz HC; Romo D; Liu JO
J Biol Chem; 2009 Aug; 284(35):23613-21. PubMed ID: 19570977
[TBL] [Abstract][Full Text] [Related]
15. Eukaryotic initiation factor 2alpha-independent pathway of stress granule induction by the natural product pateamine A.
Dang Y; Kedersha N; Low WK; Romo D; Gorospe M; Kaufman R; Anderson P; Liu JO
J Biol Chem; 2006 Oct; 281(43):32870-8. PubMed ID: 16951406
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of translation initiation as cancer therapeutics.
Lindqvist L; Pelletier J
Future Med Chem; 2009 Dec; 1(9):1709-22. PubMed ID: 21425987
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of small molecules targeting eIF4A.
Naineni SK; Itoua Maïga R; Cencic R; Putnam AA; Amador LA; Rodriguez AD; Jankowsky E; Pelletier J
RNA; 2020 May; 26(5):541-549. PubMed ID: 32014999
[TBL] [Abstract][Full Text] [Related]
18. Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor.
Iwasaki S; Floor SN; Ingolia NT
Nature; 2016 Jun; 534(7608):558-61. PubMed ID: 27309803
[TBL] [Abstract][Full Text] [Related]
19. Translational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence.
Raza F; Waldron JA; Quesne JL
Biochem Soc Trans; 2015 Dec; 43(6):1227-33. PubMed ID: 26614665
[TBL] [Abstract][Full Text] [Related]
20. eIF4A inhibition prevents the onset of cytokine-induced muscle wasting by blocking the STAT3 and iNOS pathways.
Cramer Z; Sadek J; Vazquez GG; Di Marco S; Pause A; Pelletier J; Gallouzi IE
Sci Rep; 2018 May; 8(1):8414. PubMed ID: 29849089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
